透過您的圖書館登入
IP:3.144.103.60
  • 學位論文

生技醫療產業研發費用,專利權與公司市場價值之攸關性研究

The Relationship Between Research and Development, Patent, and Market Value in Biotechnology Industry

指導教授 : 阮金聲 吳徐哲
若您是本文的作者,可授權文章由華藝線上圖書館中協助推廣。

摘要


本文主要研究企業研究與發展活動(以下簡稱R&D)對企業股價之影響,同時R&D成果所累積的專利權是否能帶來企業的股價的效益。我國在進入世界貿易組織(WTO)後,面對國外企業資本與技術的挑戰,尤其是價值鏈長、風險高、高研發成本、高知識內涵等特性的生技醫療產業,如此的產業特性,使得生技醫療公司在產品上市前,所有研發投入多以「費用」形式列帳,儲存在階段性的開發成果中,一旦R&D成果能被具體執行時,公司會藉由智慧財產的保護與管理來鞏固其R&D成果,當智慧財產若經過通盤妥善的規劃經營與管理,且加上由專利權法產生的排他性,多能有效的讓企業擁有競爭優勢籌碼。 本文研究對象將針對2001-2011年台灣上市櫃生技醫療公司,來探討其研R&D投資與公司所擁有的專利權數及類別對公司股價走向的影響。目前公司財報為了便於分析,大都將R&D活動以當期費用認列企業當期之R&D支出,但研究發現依據專利權數量來作為投資研究與分析是否繼續增加R&D活動將會是最有效的指標,所以R&D活動除會影響其當期的經營績效與市場價值外,若進一步產生專利權時就會有更明顯的實質效果。實證結果發現,企業R&D投入與累積專利權數量及類別將會對企業經營績效產生正面效益。希冀本研究可供實務界參考,將有助於公司提升研發品質與市場競爭力。

關鍵字

研發活動 專利權 股價 生技醫療

並列摘要


This study focuses the relationship between the market value and research and development activities(R&D). Besides, this study explores the patent can bring the benefits for stock price. After TAIWAN participated in the World Trade Organization (WTO), the challenges are from the capital and technology of foreign enterprises. Especially, the characteristic of long value chain, high-risk, high cost of research and development are belong to high knowledge based content in the biotech medical industry. So the R&D investment is accounted for mostly the form of a “expense” before the products to market. Once the results of R&D can be specifically implemented, the company will consolidate its R&D achievements by the protection and management of intellectual property. Based on appropriate planning and management after R&D results generated by the patents, companies can keep a stronger competitive advantage. This study used the listed of OTC biotech and medical companies in Taiwan from 2001 to 2011. This study aims on the effect between the stock price, R&D investment, patent quantity and types. In order to facilitate the analysis, most of the R&D expenditure is recognized in the current period of R&D expense. Using patent quantity and types analyze whether they are effective indicators. The R&D investment will affect its current operating performance and market value, if the patent are available. The results showed that R&D investment, patent quantity and types will produce positive effects on business performance. The findings of this research can be a reference for practitioners and researchers.

參考文獻


3. 王元章、林泓佐、謝志正,2005,研發支出與獎酬決策之雙刃性效果,財務金融學刊,第13卷第3期,頁79-143。
5. 王曉雯、王泰昌、吳明政,2008,企業經營型態與研發活動績效,管理學報,第25卷第2期,頁173-193。
6. 王祝三、莊雅雪及郭勁甫,2009,公司治理、投資與公司價值之關聯性,東吳經濟商學學報,第66期,頁69-114。
9. 汪倩人、賴廷松,2008,研究發展、專利與健保合作對於廠商經營績效的影響─台灣生物科技產業之研究,朝陽商管評論,第7卷第4期,頁
16. 金成隆、林修葳、邱煒恒,2005,研究發展支出與資本支出的價值攸關性:以企業生命週期論析,中山管理評論,第13卷第2期,頁617-

被引用紀錄


郭庭筠(2016)。探討臺灣生技產業經營績效-以臺灣上市櫃公司為例〔碩士論文,朝陽科技大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0078-1108201714023744

延伸閱讀